Bernhard Hellmich

14.2k total citations · 4 hit papers
160 papers, 6.2k citations indexed

About

Bernhard Hellmich is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Bernhard Hellmich has authored 160 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Pulmonary and Respiratory Medicine, 90 papers in Rheumatology and 35 papers in Physiology. Recurrent topics in Bernhard Hellmich's work include Vasculitis and related conditions (117 papers), Otitis Media and Relapsing Polychondritis (35 papers) and Sarcoidosis and Beryllium Toxicity Research (33 papers). Bernhard Hellmich is often cited by papers focused on Vasculitis and related conditions (117 papers), Otitis Media and Relapsing Polychondritis (35 papers) and Sarcoidosis and Beryllium Toxicity Research (33 papers). Bernhard Hellmich collaborates with scholars based in Germany, United Kingdom and United States. Bernhard Hellmich's co-authors include Wolfgang L. Gross, Alfred Mahr, Thomas Häuser, Peter A. Merkel, Raashid Luqmani, Jan Willem Cohen-Tervaert, Elena Csernok, David Jayne, James Witter and Hasan Yazıcı and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Bernhard Hellmich

140 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

2006 913 citations Bernhard Hellmich, Alfred Mahr et al. Annals of the Rheumatic Diseases profile →
EULAR recommendations for the management of primary small and medium vessel vasculitis

2008 618 citations María C. Cid, Bhaskar Dasgupta et al. Annals of the Rheumatic Diseases profile →
EULAR recommendations for the management of large vessel vasculitis

2008 431 citations María C. Cid, Bhaskar Dasgupta et al. Annals of the Rheumatic Diseases profile →
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

2025 16 citations Wolfgang Schmidt, Nader Khalidi et al. profile →

Peers

Countries citing papers authored by Bernhard Hellmich

Since Specialization

Citations

This map shows the geographic impact of Bernhard Hellmich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Hellmich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Hellmich more than expected).

Fields of papers citing papers by Bernhard Hellmich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Hellmich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Hellmich. The network helps show where Bernhard Hellmich may publish in the future.

Co-authorship network of co-authors of Bernhard Hellmich

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Hellmich. A scholar is included among the top collaborators of Bernhard Hellmich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Hellmich. Bernhard Hellmich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis 2025 ·Nature Reviews Rheumatology ·Marta Casal Moura, Peter A. Merkel, David Jayne, María C. Cid, Neil Basu, Bernhard Hellmich, Benjamin Terrier, Abraham Rutgers, Jennifer Gordon, (unknown), Joyce Kullman, Carol A. Langford, Ingeborg M. Bajema, Duvuru Geetha, Fernando C. Fervenza, A. Richard Kitching, John H. Stone, Ulrich Specks, Andreas Kronbichler	0
2	Early Diagnosis and Treatment in Patients With Eosinophilic Granulomatosis With Polyangiitis 2025 ·The Journal of Allergy and Clinical Immunology In Practice ·Salman Siddiqui, (unknown), Sara Monti, Bernhard Hellmich	0
3	Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica 2025 ·Lara D. Veeken ·Frank Buttgereit, (unknown), (unknown), (unknown), (unknown), Thomas Daikeler, Christina Duftner, (unknown), Ulrike Garske, Bernhard Hellmich, Diego Kyburz, Anett Reißhauer, Monika Reuß‐Borst, Kathrin Scheuermann, (unknown), Eric L. Matteson, Christian Dejaco	0
4	The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis 2025 ·Arthritis & Rheumatology ·(unknown), Bernhard Hellmich, Arnaud Bourdin, David Jayne, Florence Roufosse, Nader Khalidi, (unknown), Ying Fan, Christopher McCrae, Sofia Necander, Eva Rodríguez‐Suárez, Anat Shavit, (unknown), Peter A. Merkel, (unknown)	0
5	Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis 2024 ·RMD Open ·(unknown), Bernhard Hellmich, You‐Shan Feng, Christian Löffler	5
6	MEPOLIZUMAB REDUCED STEROID BURDEN FOR PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS WITH AND WITHOUT A VASCULITIC PHENOTYPE 2023 ·CHEST Journal ·(unknown), (unknown), David Jayne, Bernhard Hellmich, Paneez Khoury, (unknown), (unknown), (unknown), Benjamin Terrier	0
7	Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis 2023 ·RMD Open ·Jan Henrik Schirmer, Beatriz Sánchez‐Álamo, Bernhard Hellmich, David Jayne, Sara Monti, Raashid Luqmani, Gunnar Tómasson	9
8	Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV 2023 ·RMD Open ·Beatriz Sánchez‐Álamo, Jan Henrik Schirmer, Bernhard Hellmich, David Jayne, Sara Monti, Gunnar Tómasson, Raashid Luqmani	8
9	Interstitielle Lungenerkrankungen 2023 ·PubMed Central ·(unknown), (unknown), Bernhard Hellmich, Claus Peter Heußel, Mark Kriegsmann, Markus Polke, Michael Kreuter	0
10	Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study 2022 ·Clinical and Experimental Rheumatology ·(unknown), (unknown), Anja Kerstein, Gabriela Riemekasten, (unknown), Bernhard Hellmich, Nils Venhoff, Jens Thiel, (unknown), (unknown), Peter Lamprecht	4
11	GCA management guidelines — vive la différence? 2021 ·Nature Reviews Rheumatology ·Bernhard Hellmich, Frank Buttgereit	3
12	ANCA-assoziierte Vaskulitiden nach Erreichen einer Remission 2020 ·Zeitschrift für Rheumatologie ·Bernhard Hellmich	2
13	Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis 2019 ·RMD Open ·Sara Monti, Ana Águeda, Raashid Luqmani, Frank Buttgereit, María C. Cid, Christian Dejaco, Alfred Mahr, Cristina Ponte, Carlo Salvarani, Wolfgang Schmidt, Bernhard Hellmich	47
14	Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis 2019 ·RMD Open ·Ana Águeda, Sara Monti, Raashid Luqmani, Frank Buttgereit, María C. Cid, Bhaskar Dasgupta, Christian Dejaco, Alfred Mahr, Cristina Ponte, Carlo Salvarani, Wolfgang Schmidt, Bernhard Hellmich	43
15	Anti-neutrophil cytoplasm antibodies (ANCA): Recent methodological advances—Lead to new consensus recommendations for ANCA detection 2018 ·Journal of Immunological Methods ·Elena Csernok, (unknown), Bernhard Hellmich	6
16	Remissionsinduktion bei ANCA-assoziierten Vaskulitiden 2013 ·Zeitschrift für Rheumatologie ·Bernhard Hellmich	2
17	Hypereosinophiles Syndrom und Churg-Strauss-Syndrom: Ist die Differenzierung der Syndrome klinisch relevant? 2008 ·Der Internist ·Bernhard Hellmich, Konstanze Holl‐Ulrich, Hartmut Merz, Wolfgang L. Gross	1
18	Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis 2006 ·Annals of the Rheumatic Diseases ·Bernhard Hellmich, Oliver Floßmann, Raashid Luqmani	3
19	Circulating transforming growth factor β1 (TGFβ1) is elevated by extensive exercise 2002 ·European Journal of Applied Physiology ·Steffen Hering, (unknown), Henry Schulz, Bernhard Hellmich, H. Schatz, Andreas Pfeiffer	30
20	Low Fcγ receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty’s syndrome or systemic lupus erythematosus 2002 ·The American Journal of Medicine ·Bernhard Hellmich, Elena Csernok, Masja de Haas, (unknown), Helmut Schatz, Wolfgang L. Gross, A. Schnabel	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact